|
|
|
Volumn 65, Issue 4, 1997, Pages 495-497
|
|
A multicenter study of recombinanat inferon-alpha2b in the treatment of multibacillary leprosy
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOFAZIMINE;
DAPSONE;
MACROLIDE;
QUINOLONE DERIVATIVE;
RECOMBINANT ALPHA2B INTERFERON;
RIFAMPICIN;
LEPROMIN;
LEPROSTATIC AGENT;
RECOMBINANT INTERFERON;
ADULT;
ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY;
BACTERICIDAL ACTIVITY;
CELL KILLING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG HALF LIFE;
FEMALE;
HUMAN;
KILLER CELL;
LEPROMIN TEST;
LEPROSY;
LETTER;
MALE;
MULTICENTER STUDY;
SKIN ABSORPTION;
DRUG COMBINATION;
DRUG EFFECT;
ERYTHEMA;
LEPROMATOUS LEPROSY;
RANDOMIZED CONTROLLED TRIAL;
CLOFAZIMINE;
DAPSONE;
DRUG THERAPY, COMBINATION;
ERYTHEMA;
HUMANS;
INTERFERON TYPE I, RECOMBINANT;
LEPROMIN;
LEPROSTATIC AGENTS;
LEPROSY, LEPROMATOUS;
RIFAMPIN;
|
|
EID: 0031308601
PISSN: 0148916X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (1)
|
|
References (13)
|
